Company intelligence / Profile preview

DanSheng Medical Technology

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

DanSheng Medical Technology is a Chinese biotechnology company specializing in liquid biopsy and advanced diagnostic solutions for oncology. The company focuses on the development of high-sensitivity platforms for the enrichment and detection of circulating tumor cells (CTCs) and exosomes using proprietary microfluidic technology. Their products are designed to support early cancer screening, treatment monitoring, and companion diagnostics. By integrating micro-nano manufacturing with molecular biology, DanSheng provides clinical-grade tools for precision medicine in various solid tumors.

Therapeutic areas: Oncology
Modalities: DiagnosticIn vitro diagnosticBiologicAntibody
Industry: Molecular Diagnostics

Partnerships

Peking University Cancer HospitalTsinghua University

Beyond the preview

Go deeper on DanSheng Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DanSheng Medical Technology.

Explore the full profile